Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.
For more information on how to use this blog, the HCV drug pipeline, and for more information on HCV clinical trials click here
Thursday, March 22, 2012
Liver disease deaths jump 25% in England: study
Alcohol-related liver disease in Britain, notorious for its binge-drinking culture, accounted for over a third (37 percent) of the deaths, according to the National End of Life Care Intelligence Network report.